BR112022019616A2 - Compostos terpenofenólicos e seu uso - Google Patents

Compostos terpenofenólicos e seu uso

Info

Publication number
BR112022019616A2
BR112022019616A2 BR112022019616A BR112022019616A BR112022019616A2 BR 112022019616 A2 BR112022019616 A2 BR 112022019616A2 BR 112022019616 A BR112022019616 A BR 112022019616A BR 112022019616 A BR112022019616 A BR 112022019616A BR 112022019616 A2 BR112022019616 A2 BR 112022019616A2
Authority
BR
Brazil
Prior art keywords
compounds
cbd
ene
tetrahydro
prop
Prior art date
Application number
BR112022019616A
Other languages
English (en)
Portuguese (pt)
Inventor
George Stott Colin
R Heap Charles
Gurusankar Ramamoorthy
Original Assignee
Phytotherapeutix Ltd
Alinova Biosciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phytotherapeutix Ltd, Alinova Biosciences Ltd filed Critical Phytotherapeutix Ltd
Publication of BR112022019616A2 publication Critical patent/BR112022019616A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/32—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions without formation of -OH groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/38—Alcohols containing six-membered aromatic rings and other rings and having unsaturation outside the aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C07C37/001—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by modification in a side chain
    • C07C37/003—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by modification in a side chain by hydrogenation of an unsaturated part
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C07C37/11—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions increasing the number of carbon atoms
    • C07C37/14—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions increasing the number of carbon atoms by addition reactions, i.e. reactions involving at least one carbon-to-carbon unsaturated bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • C07C39/15—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings with all hydroxy groups on non-condensed rings, e.g. phenylphenol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing six-membered aromatic rings and other rings, with unsaturation outside the aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/09—Geometrical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR112022019616A 2020-03-31 2021-03-31 Compostos terpenofenólicos e seu uso BR112022019616A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063003270P 2020-03-31 2020-03-31
PCT/GB2021/050812 WO2021198692A1 (en) 2020-03-31 2021-03-31 Terpenophenolic compounds and their use

Publications (1)

Publication Number Publication Date
BR112022019616A2 true BR112022019616A2 (pt) 2022-12-06

Family

ID=75426633

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022019616A BR112022019616A2 (pt) 2020-03-31 2021-03-31 Compostos terpenofenólicos e seu uso

Country Status (11)

Country Link
US (2) US12552733B2 (enExample)
EP (1) EP4126800A1 (enExample)
JP (1) JP7714571B2 (enExample)
KR (1) KR20230121960A (enExample)
CN (1) CN116194431B (enExample)
AU (1) AU2021248627A1 (enExample)
BR (1) BR112022019616A2 (enExample)
GB (3) GB2628746A (enExample)
IL (1) IL296861A (enExample)
MX (1) MX2022011832A (enExample)
WO (1) WO2021198692A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3959193A4 (en) * 2019-05-23 2022-07-13 Kare Chemical Technologies Inc. Catalytic cannabinoid processes and precursors

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL136839A (en) * 2000-06-16 2006-12-10 Yissum Res Dev Co Pharmaceutical compositions comprising cannabidiol derivatives, and processes for the preparation of same
EP2578561A1 (en) 2005-09-29 2013-04-10 Albany Molecular Research, Inc. Processes for the production of cannabidiol derivatives and intermediates thereof
AU2012201041B2 (en) * 2005-09-29 2012-12-06 Albany Molecular Research, Inc. Process for production of delta-9-tetrahydrocannabinol
DK2176208T3 (en) * 2007-07-30 2015-04-27 Zynerba Pharmaceuticals Inc Prodrugs of cannabidiol, compositions containing prodrugs of cannabidiol and methods of use thereof
DE102009019322A1 (de) 2009-04-30 2010-11-11 The Health Concept Gmbh Verfahren zur Herstellung von Synthetischen Cannabinoiden
TWI583374B (zh) * 2010-03-30 2017-05-21 Gw伐瑪有限公司 使用植物大麻素次大麻二酚(cbdv)來治療癲癇之用途
WO2014177593A1 (en) 2013-04-29 2014-11-06 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Amorfrutin analogs as ppargamma-modulators
US9526706B1 (en) 2015-06-16 2016-12-27 Hong Kong Baptist University Method of using dihydro-resveratrol for treating acute pancreatitis and associated pulmonary injury
US9738581B2 (en) * 2015-06-16 2017-08-22 Hong Kong Baptist University Method of using dihydro-resveratrol or its stilbenoid derivatives and/or chemical variants in treatments of fibrotic and diabetic conditions
US20170008869A1 (en) * 2015-07-10 2017-01-12 Noramco, Inc. Process for the production of cannabidiol and delta-9-tetrahydrocannabinol
CN109311838A (zh) 2016-04-15 2019-02-05 蒂温诺特技术有限公司 大麻素前药的生物合成
US20170362195A1 (en) 2016-06-16 2017-12-21 Full Spectrum Laboratories Ltd Methods for the manufacture of cannabinoid prodrugs, pharmaceutical formulations and their use
US10640482B2 (en) 2017-07-21 2020-05-05 University Of South Florida Synthesis of cannabinoids
CN111372907A (zh) 2017-09-01 2020-07-03 普优峰全球股份有限公司 合成大麻二酚组合物和用于制备其的方法
DE102017008367B4 (de) * 2017-09-06 2019-06-13 Sumitomo Wiring Systems, Ltd. Abschirmverbinder und Verfahren zum Zusammenbauen desselben
EP3840854A4 (en) * 2018-08-20 2022-06-29 Bessor Pharma, LLC Novel cannabinoids and cannabinoid acids and their derivatives
EP3959193A4 (en) * 2019-05-23 2022-07-13 Kare Chemical Technologies Inc. Catalytic cannabinoid processes and precursors
CA3150642A1 (en) * 2019-09-09 2021-03-18 Kamaluddin Abdur-Rashid CANNABINOID DERIVATIVES, PRECURSORS AND USES
CA3150646A1 (en) * 2019-09-10 2021-03-18 Kamaluddin Abdur-Rashid CANNABINOID DERIVATIVES AND PRECURSORS, AND ASYMMETRICAL SYNTHESIS THEREOF

Also Published As

Publication number Publication date
GB2609814A (en) 2023-02-15
MX2022011832A (es) 2023-03-03
GB2595355A (en) 2021-11-24
WO2021198692A1 (en) 2021-10-07
CN116194431B (zh) 2026-01-02
CA3177186A1 (en) 2021-10-07
IL296861A (en) 2022-11-01
CN116194431A (zh) 2023-05-30
AU2021248627A1 (en) 2022-12-01
EP4126800A1 (en) 2023-02-08
US20230227390A1 (en) 2023-07-20
US20230225985A1 (en) 2023-07-20
GB202410277D0 (en) 2024-08-28
JP7714571B2 (ja) 2025-07-29
US12552733B2 (en) 2026-02-17
GB2628746A (en) 2024-10-02
GB2609814B (en) 2024-08-28
GB202104690D0 (en) 2021-05-12
JP2023520794A (ja) 2023-05-19
GB202215746D0 (en) 2022-12-07
KR20230121960A (ko) 2023-08-22

Similar Documents

Publication Publication Date Title
Suárez et al. Rate, amount, and distribution pattern of alimentary fluid transfer via trophallaxis in three species of termites (Isoptera: Rhinotermitidae, Termopsidae)
World Health Organization Annual global move for health initiative: a concept paper
ES2092093T3 (es) Estructura que comprende dos o mas elementos de construccion alargados, dotados de acoplamiento por nervio y ranura.
CY1126152T1 (el) Ενωσεις-αναστολεις της rip1 και μεθοδοι παρασκευης και χρησης αυτων
BRPI0415130A (pt) elemento de preensão, e, artigo
ECSP034774A (es) Pirazolopirimmidinas como agentes terapeuticos
BRPI0512065B8 (pt) artigo absorvente possuindo núcleo absorvente moldado formado sobre um substrato
MX2021005945A (es) Ureas ciclicas.
GT200300294A (es) Compuestos de indazol y composiciones farmaceuticas para inhibir proteinquinasas y procedimientos para su uso
BRPI0607238A2 (pt) anticorpos anti-interferon gama humanos e métodos de seu uso
AR038907A1 (es) Mezclas fungicidas a base de protioconazol con un insecticida
ATE144681T1 (de) Wasserbasierte, lösungsmittel- und emulgatorfreie mikrobizide wirkstoffkombination
BR9706386A (pt) Antagonistas do receptor de vitronectina, sua preparação e seu us0
NO178261C (no) Substituerte diaminoftalimider og analoger, farmasöytiske preparater inneholdende dem samt deres anvendelse i medikamenter
ES2172600T3 (es) Composicion farmaceutica que comprende lamotrigina.
BR9909679A (pt) Proteìna tao quinases e processos para seu uso
MX2022011832A (es) Compuestos terpenofenolicos y su uso.
BR0312131A (pt) Formulações em pó
Clark et al. Competitive antagonism of leukocytic pyrogen by sodium salicylate and acetaminophen
UY28583A1 (es) Forma de presentación del naproxeno sodico
ES2061550T3 (es) Vinilcefalosporinas substituidas, procedimiento para su preparacion y su uso como medicamento.
YU et al. Length and Width-to-length Ratio of Clinical Crown of Chinese Han Adults in Wuhan.
Sladden Thrombocytopenic purpura and rubella
YU151991A (sh) Postupak za uništavanje venturia
Terschüren et al. S 03. 5: In home use of pesticides as a risk factor for leukaemia and malignant lymphoma– results of the Northern Germany Leukaemia and Lymphoma Study(NLL)

Legal Events

Date Code Title Description
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]